CD24 and neoplasm: Both genetic ablation of CD24 or Siglec-10 and the monoclonal antibody blockade of the CD24–Siglec-10 interaction enhance the phagocytosis of macrophages to tumor cells, inhibit tumor growth, and prolong overall survival time [155].